Published in Dev Biol on April 15, 1998
Heart induction by Wnt antagonists depends on the homeodomain transcription factor Hex. Genes Dev (2005) 3.61
Alternative splicing events identified in human embryonic stem cells and neural progenitors. PLoS Comput Biol (2007) 2.71
Nodal-dependent Cripto signaling promotes cardiomyogenesis and redirects the neural fate of embryonic stem cells. J Cell Biol (2003) 1.52
The alpha catalytic subunit of protein kinase CK2 is required for mouse embryonic development. Mol Cell Biol (2007) 1.52
Reduced genomic cytosine methylation and defective cellular differentiation in embryonic stem cells lacking CpG binding protein. Mol Cell Biol (2005) 1.26
Role of Cripto-1 during epithelial-to-mesenchymal transition in development and cancer. Am J Pathol (2012) 1.20
Human embryonic stem cells and cardiac repair. Transplant Rev (Orlando) (2008) 1.15
Gene targeting of CK2 catalytic subunits. Mol Cell Biochem (2008) 1.12
Role of Cripto-1 in stem cell maintenance and malignant progression. Am J Pathol (2010) 1.09
Multiple functions of Cerberus cooperate to induce heart downstream of Nodal. Dev Biol (2006) 1.06
The Polycomb-group gene Rae28 sustains Nkx2.5/Csx expression and is essential for cardiac morphogenesis. J Clin Invest (2002) 1.01
CXXC finger protein 1 contains redundant functional domains that support embryonic stem cell cytosine methylation, histone methylation, and differentiation. Mol Cell Biol (2009) 1.00
Dax1 up-regulates Oct4 expression in mouse embryonic stem cells via LRH-1 and SRA. Mol Endocrinol (2010) 0.97
Cripto-1 is required for hypoxia to induce cardiac differentiation of mouse embryonic stem cells. Am J Pathol (2009) 0.96
Cardiomyogenic stem and progenitor cell plasticity and the dissection of cardiopoiesis. J Mol Cell Cardiol (2008) 0.94
Cripto/GRP78 modulation of the TGF-β pathway in development and oncogenesis. FEBS Lett (2012) 0.91
Regulation of human Cripto-1 expression by nuclear receptors and DNA promoter methylation in human embryonal and breast cancer cells. J Cell Physiol (2013) 0.82
Cardiac myocyte differentiation: the Nkx2.5 and Cripto target genes in P19 clone 6 cells. Funct Integr Genomics (2005) 0.81
Hhex and Cer1 mediate the Sox17 pathway for cardiac mesoderm formation in embryonic stem cells. Stem Cells (2014) 0.80
Nkx2-5 Regulates Tdgf1 (Cripto) Early During Cardiac Development. J Clin Exp Cardiolog (2012) 0.78
Cripto is essential to capture mouse epiblast stem cell and human embryonic stem cell pluripotency. Nat Commun (2016) 0.76
Activin A Modulates CRIPTO-1/HNF4α(+) Cells to Guide Cardiac Differentiation from Human Embryonic Stem Cells. Stem Cells Int (2017) 0.75
Why don't they beat?: Cripto, apelin/APJ, and myocardial differentiation. Circ Res (2009) 0.75
Ectopic expression of Cripto-1 in transgenic mouse embryos causes hemorrhages, fatal cardiac defects and embryonic lethality. Sci Rep (2016) 0.75
Tomoregulin-1 prevents cardiac hypertrophy after pressure overload in mice by inhibiting TAK1-JNK pathways. Dis Model Mech (2015) 0.75
Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nat Med (2001) 6.73
Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor. Proc Natl Acad Sci U S A (1991) 3.95
Isolation of human glucose-6-phosphate dehydrogenase (G6PD) cDNA clones: primary structure of the protein and unusual 5' non-coding region. Nucleic Acids Res (1986) 3.86
Vinculin knockout results in heart and brain defects during embryonic development. Development (1998) 3.44
alpha-Catenin-vinculin interaction functions to organize the apical junctional complex in epithelial cells. J Cell Biol (1998) 2.74
The Egr-1 transcription factor directly activates PTEN during irradiation-induced signalling. Nat Cell Biol (2001) 2.71
Structural analysis of the X-linked gene encoding human glucose 6-phosphate dehydrogenase. EMBO J (1986) 2.64
The transcription factor Egr1 is a direct regulator of multiple tumor suppressors including TGFbeta1, PTEN, p53, and fibronectin. Cancer Gene Ther (2006) 2.24
The orphan receptor ALK7 and the Activin receptor ALK4 mediate signaling by Nodal proteins during vertebrate development. Genes Dev (2001) 2.17
Transcription of c-onc genes c-rasKi and c-fms during mouse development. Mol Cell Biol (1983) 2.14
Expression of c-onc genes: c-fos transcripts accumulate to high levels during development of mouse placenta, yolk sac and amnion. EMBO J (1983) 2.08
The synthesis and storage of histones during the oogenesis of Xenopus laevis. Dev Biol (1977) 1.99
Two alternative mRNAs coding for the angiogenic factor, placenta growth factor (PlGF), are transcribed from a single gene of chromosome 14. Oncogene (1993) 1.83
Targeted disruption of vinculin genes in F9 and embryonic stem cells changes cell morphology, adhesion, and locomotion. Proc Natl Acad Sci U S A (1995) 1.82
UV activates growth factor receptors via reactive oxygen intermediates. J Cell Biol (1996) 1.70
cDNA sequences of human glucose 6-phosphate dehydrogenase cloned in pBR322. Nature (1981) 1.69
Rescue of the mutant phenotype by reexpression of full-length vinculin in null F9 cells; effects on cell locomotion by domain deleted vinculin. J Cell Sci (1998) 1.69
Decreased Egr-1 expression in human, mouse and rat mammary cells and tissues correlates with tumor formation. Int J Cancer (1997) 1.66
The related FLT4, FLT1, and KDR receptor tyrosine kinases show distinct expression patterns in human fetal endothelial cells. J Exp Med (1993) 1.62
Histone synthesis in early amphibian development: histone and DNA syntheses are not co-ordinated. J Mol Biol (1974) 1.61
Tissue and cell type-specific expression of two human c-onc genes. Nature (1983) 1.53
Differential expression of epidermal growth factor-related proteins in human colorectal tumors. Proc Natl Acad Sci U S A (1991) 1.52
Immunobiological activities of Helicobacter pylori porins. Infect Immun (1994) 1.51
The localization and synthesis of some collagen types in developing mouse embryos. Cell (1979) 1.51
The Gorlin-Goltz syndrome: case report. Ophthalmologica (1990) 1.51
Epidermal growth factor receptors. Mol Cell Biochem (1981) 1.50
Controlled study using wireless capsule endoscopy for the evaluation of the small intestine in chronic refractory pouchitis. Aliment Pharmacol Ther (2007) 1.49
Molecular characterization of a gene of the 'EGF family' expressed in undifferentiated human NTERA2 teratocarcinoma cells. EMBO J (1989) 1.40
Placenta growth factor-1 is chemotactic, mitogenic, and angiogenic. Lab Invest (1997) 1.39
Expression of vascular endothelial growth factor and placenta growth factor in human placenta. Biol Reprod (1997) 1.37
Biochemical markers of the progress of differentiation in cloned teratocarcinoma cell lines. Eur J Biochem (1977) 1.36
Differences in elasticity of vinculin-deficient F9 cells measured by magnetometry and atomic force microscopy. Exp Cell Res (1998) 1.31
Characterization of human centromeric regions of specific chromosomes by means of alphoid DNA sequences. Am J Hum Genet (1987) 1.30
Role of laminin in epithelium formation by F9 aggregates. J Cell Biol (1983) 1.30
Abrogation of the Cripto gene in mouse leads to failure of postgastrulation morphogenesis and lack of differentiation of cardiomyocytes. Development (1999) 1.29
The heat shock response in HeLa cells is accompanied by elevated expression of the c-fos proto-oncogene. Mol Cell Biol (1987) 1.28
Human papillomavirus and vaccination: knowledge, attitudes, and behavioural intention in adolescents and young women in Italy. Br J Cancer (2008) 1.27
Epidermal growth factor receptors increase during the differentiation of embryonal carcinoma cells. Nature (1979) 1.27
Characterization of the DNA-binding properties of the early growth response-1 (Egr-1) transcription factor: evidence for modulation by a redox mechanism. DNA Cell Biol (1993) 1.26
Transcriptional regulation of the tissue factor gene in human epithelial cells is mediated by Sp1 and EGR-1. J Biol Chem (1996) 1.26
A network of p73, p53 and Egr1 is required for efficient apoptosis in tumor cells. Cell Death Differ (2006) 1.26
Vascular growth factors and receptors in capillary hemangioblastomas and hemangiopericytomas. Am J Pathol (1996) 1.25
Functional EGF receptors are present on mouse embryo tissues. Nature (1981) 1.25
Intermediate filament protein synthesis in preimplantation murine embryos. Dev Biol (1983) 1.24
Epithelial layer formation in differentiating aggregates of F9 embryonal carcinoma cells. J Cell Biol (1983) 1.23
The ontogeny of expression of murine metallothionein: comparison with the alpha-fetoprotein gene. Dev Biol (1984) 1.18
Changes in the rate of histone synthesis during oocyte maturation and very early development of Xenopus laevis. Dev Biol (1977) 1.15
Membrane-anchorage of Cripto protein by glycosylphosphatidylinositol and its distribution during early mouse development. Mech Dev (2000) 1.15
p53 and Egr-1 additively suppress transformed growth in HT1080 cells but Egr-1 counteracts p53-dependent apoptosis. Oncogene (1999) 1.14
Egr-1 negatively regulates human tumor cell growth via the DNA-binding domain. Cancer Res (1995) 1.12
Epidermal growth factor receptor mRNA and protein increase after the four-cell preimplantation stage in murine development. Dev Biol (1992) 1.11
Molecular heterogeneity of steroid sulfatase deficiency: a multicenter study on 57 unrelated patients, at DNA and protein levels. Genomics (1989) 1.09
Effects of diesel exhaust particles on human lung epithelial cells: an in vitro study. Respir Med (2007) 1.09
An extensive search for RFLP in the human glucose-6-phosphate dehydrogenase locus has revealed a silent mutation in the coding sequence. Am J Hum Genet (1988) 1.07
The differentiation of teratocarcinoma stem cells is marked by the types of collagen which are synthesized. Cell (1979) 1.07
The placenta growth factor gene of the mouse. Mamm Genome (1996) 1.07
Expression of chicken vinculin complements the adhesion-defective phenotype of a mutant mouse F9 embryonal carcinoma cell. J Cell Biol (1993) 1.06
Reciprocal modulation between Sp1 and Egr-1. J Cell Biochem (1997) 1.05
The murine cripto gene: expression during mesoderm induction and early heart morphogenesis. Development (1993) 1.05
Expression of cripto, a novel gene of the epidermal growth factor gene family, leads to in vitro transformation of a normal mouse mammary epithelial cell line. Cancer Res (1991) 1.05
Structure-function analysis of the EGF-CFC family member Cripto identifies residues essential for nodal signalling. Development (2001) 1.05
Microbiological quality of the water of recreational and rehabilitation pools: a 2-year survey in Naples, Italy. Public Health (2009) 1.03
Suppression of v-sis-dependent transformation by the transcription factor, Egr-1. Oncogene (1994) 1.02
Expression of teratocarcinoma-derived growth factor-1 (TDGF-1) in testis germ cell tumors and its effects on growth and differentiation of embryonal carcinoma cell line NTERA2/D1. Oncogene (1997) 1.01
A biological role for Egr-1 in cell survival following ultra-violet irradiation. Oncogene (1995) 0.98
Common glucose-6-phosphate dehydrogenase (G6PD) variants from the Italian population: biochemical and molecular characterization. Ann Hum Genet (1990) 0.98
Partial purification and characterization of the messenger RNA for human glucose-6-phosphate dehydrogenase. Mol Biol Med (1984) 0.98
The crystal structure of human placenta growth factor-1 (PlGF-1), an angiogenic protein, at 2.0 A resolution. J Biol Chem (2000) 0.98
RAR and RXR selective ligands cooperatively induce apoptosis and neuronal differentiation in P19 embryonal carcinoma cells. FASEB J (1996) 0.98
Short-term treatment with infliximab in chronic refractory pouchitis and ileitis. Aliment Pharmacol Ther (2008) 0.97
Human lymphoblastoid cells produce extracellular matrix-degrading enzymes and induce endothelial cell proliferation, migration, morphogenesis, and angiogenesis. Int J Clin Lab Res (1998) 0.97
The ontogeny of epidermal growth factor receptors during mouse development. Dev Biol (1984) 0.97
The expression of megalin (gp330) and LRP diverges during F9 cell differentiation. J Cell Sci (1995) 0.97
Enolase isoenzymes as markers of differentiation in teratocarcinoma cells and normal tissues of mouse. Dev Biol (1978) 0.95
The location and synthesis of transferrin in mouse embryos and teratocarcinoma cells. Dev Biol (1982) 0.95
Method for cloning in vivo targets of the Egr-1 transcription factor. Biotechniques (2000) 0.94
Expression of EGF receptor and transferrin by F9 and PC13 teratocarcinoma cells. Differentiation (1984) 0.94
Properties of Yersinia enterocolitica porins: interference with biological functions of phagocytes, nitric oxide production and selective cytokine release. Res Microbiol (1994) 0.93
Deletions of the steroid sulphatase gene in "classical" X-linked ichthyosis and in X-linked ichthyosis associated with Kallmann syndrome. Hum Genet (1987) 0.92
Suppression of human fibrosarcoma cell growth by transcription factor, Egr-1, involves down-regulation of Bcl-2. Int J Cancer (1998) 0.92
Transcytosis of epidermal growth factor. The epidermal growth factor receptor mediates uptake but not transcytosis. J Biol Chem (1991) 0.92
Preparation and properties of monoclonal and polyclonal antibodies to mouse epidermal growth factor (EGF) receptors: evidence for cryptic EGF receptors in embryonal carcinoma cells. Development (1987) 0.92
Expression of Egr-1 correlates with the transformed phenotype and the type of viral latency in EBV genome positive lymphoid cell lines. Oncogene (1996) 0.92
Neovascularization in human germ cell tumors correlates with a marked increase in the expression of the vascular endothelial growth factor but not the placenta-derived growth factor. Oncogene (1996) 0.91
Egr-1 inhibits apoptosis during the UV response: correlation of cell survival with Egr-1 phosphorylation. Cell Death Differ (1998) 0.90
Isoenzyme transitions of creatine phosphokinase, aldolase and phosphoglycerate mutase in differentiating mouse cells. J Embryol Exp Morphol (1976) 0.90
The phosphorylated forms of the transcription factor, Egr-1, bind to DNA more efficiently than non-phosphorylated. Biochem Biophys Res Commun (1994) 0.89
Evidence for the existence of an early common biochemical pathway in the differentiation of F9 cells into visceral or parietal endoderm: modulation by cyclic AMP. Dev Biol (1986) 0.89
VEGF receptor subtypes KDR and FLT1 show different sensitivities to heparin and placenta growth factor. Growth Factors (1994) 0.89
Expression of cripto, a novel gene of the epidermal growth factor family, in human gastrointestinal carcinomas. Jpn J Cancer Res (1991) 0.89
Implications of antioxidant enzymes in human gastric neoplasms. Int J Mol Med (2009) 0.89
Inhibition of CRIPTO expression and tumorigenicity in human colon cancer cells by antisense RNA and oligodeoxynucleotides. Oncogene (1994) 0.89
Potential role of the cannabinoid receptor CB in the pathogenesis of erosive and non-erosive gastro-oesophageal reflux disease. Aliment Pharmacol Ther (2010) 0.89
Detection of high-mobility group proteins A1 and A2 represents a valid diagnostic marker in post-pubertal testicular germ cell tumours. J Pathol (2008) 0.88
Product of the cellular oncogene, c-fos, observed in mouse and human tissues using an antibody to a synthetic peptide. EMBO J (1985) 0.87